BioDerm

About:

BioDerm develops urine management, infection control, and catheter securement products.

Twitter/X: bioderm

Top Investors: Mountaingate Capital

Description:

Bioderm, Inc was founded to develop unique solutions for long-standing healthcare challenges that affect millions of people. The company’s products for urine management, infection control and catheter securement are based on an innovative hydrocolloid technology that seals securely to skin, providing protection from moisture and bacteria.

Total Funding Amount:

$604000

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Largo, Florida, United States

Founded Date:

1990-01-01

Contact Email:

CustomerCare(AT)BioDerm.us

Founders:

Dennis M. Kay

Number of Employees:

11-50

Last Funding Date:

2021-01-11

IPO Status:

Private

Industries: